Keyphrases
3-year Follow-up
25%
Antipsychotics
25%
Biomarker Trajectories
25%
Cardiometabolic Biomarkers
50%
Cardiometabolic Disease
100%
Cardiometabolic Outcomes
25%
Cardiovascular Disease
25%
Clinical Symptoms
100%
Clinical Trajectory
25%
Cognitive Function
25%
Cognitive Performance
25%
Cognitive Symptoms
50%
Diastolic Blood Pressure
25%
Early Identification
25%
Genetic Outcome
25%
Genetic Risk
25%
Glycated Hemoglobin A1c
25%
HbA1c Levels
25%
Hemoglobin A1c (HbA1c)
25%
High-density Lipoprotein Cholesterol (HDL-C)
25%
Increased Body Mass Index
25%
Life Expectancy
25%
Linear Logistic Regression
25%
Mediation Analysis
25%
Multinomial Logistic Regression Model
25%
Negative Symptoms
75%
Patient Identification
25%
Patients at Risk
25%
Patients with Schizophrenia
100%
Positive Symptoms
100%
Psychosis
25%
Schizophrenia Spectrum Disorders
100%
Systolic Blood Pressure
25%
Medicine and Dentistry
Biological Marker
50%
Body Mass Index
25%
Cardiovascular Disease
25%
Cognition
75%
Diastolic Blood Pressure
25%
Genetic Risk
25%
Glycated Hemoglobin
25%
Hemoglobin A1c
50%
High-Density Lipoprotein
25%
Life Expectancy
25%
Logistic Regression Analysis
25%
Negative Syndrome
75%
Positive Syndrome
100%
Schizophrenia Spectrum Disorder
100%
Symptom
100%
Systolic Blood Pressure
25%
Typical Antipsychotic
25%
Neuroscience
Body Mass Index
25%
Cognitive Function
25%
Glycosylated Hemoglobin
25%
Hemoglobin A1c
50%
High-Density Lipoprotein
25%
Negative Syndrome
75%
Positive Syndrome
100%
Schizophrenia Spectrum Disorder
100%
Typical Antipsychotic
25%